title: Cell biological mechanisms of multidrug resistance in tumors.
abstract: Multidrug resistance (MDR) is a generic term for the variety of strategies tumor cells use to evade the cytotoxic effects of anticancer drugs. MDR is characterized by a decreased sensitivity of tumor cells not only to the drug employed for chemotherapy but also to a broad spectrum of drugs with neither obvious structural homology nor common targets. This pleiotropic resistance is one of the major obstacles to the successful treatment of tumors. MDR may result from structural or functional changes at the plasma membrane or within the cytoplasm, cellular compartments, or nucleus. Molecular mechanisms of MDR are discussed in terms of modifications in detoxification and DNA repair pathways, changes in cellular sites of drug sequestration, decreases in drug-target affinity, synthesis of specific drug inhibitors within cells, altered or inappropriate targeting of proteins, and accelerated removal or secretion of drugs.
authors.affiliation: Laboratory of Cellular Biophysics, Rockefeller University, New York, NY 10021.
authors.forename: S M
authors.initials: SM
authors.lastname: Simon
authors.forename: M
authors.initials: M
authors.lastname: Schindler
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D001693:Biological Transport, Active; D002352:Carrier Proteins / Q000502:physiology; D002451:Cell Compartmentation; D002462:Cell Membrane / Q000502:physiology; D002467:Cell Nucleus / Q000502:physiology; D004351:Drug Resistance; D005089:Exocytosis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008562:Membrane Glycoproteins / Q000502:physiology; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D002352:Carrier Proteins; D008562:Membrane Glycoproteins